Show simple item record

dc.contributor.authorKing, Michelle A
dc.date.accessioned2019-09-30T04:45:32Z
dc.date.available2019-09-30T04:45:32Z
dc.date.issued2018
dc.identifier.issn1756-1833
dc.identifier.doi10.1136/bmj.k4979
dc.identifier.urihttp://hdl.handle.net/10072/387953
dc.description.abstractAbuse of pregabalin and gabapentin for their euphoric effects may only be part of the story.1 Pregabalin has also been associated with suicidal ideation234 and depressed mood.45 In a small case series, approximately 10% of patients recently started on pregabalin treatment experienced changes in mood and developed depression or suicidal ideation, or both, which improved on cessation or dose reduction.4 Monitoring for depression after starting treatment and increasing dose may also help to reduce the death toll.
dc.languageEnglish
dc.language.isoeng
dc.publisherBMJ PUBLISHING GROUP
dc.relation.ispartofjournalBritish Medical Journal (BMJ)
dc.relation.ispartofvolume363
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode1103
dc.subject.fieldofresearchcode1117
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsMedicine, General & Internal
dc.subject.keywordsGeneral & Internal Medicine
dc.titlePregabalin and gabapentin associated with depression and suicidal ideation
dc.typeJournal article
dc.type.descriptionC3 - Articles (Letter/ Note)
dcterms.bibliographicCitationKing, MA, Pregabalin and gabapentin associated with depression and suicidal ideation, British Medical Journal (BMJ), 2018, 363
dc.date.updated2019-09-30T04:44:02Z
gro.hasfulltextNo Full Text
gro.griffith.authorKing, Michelle A.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record